September 19, 2018
The Ministry of Health, Labor and Welfare (MHLW) issued a notification on September 14 announcing that the health ministry has awarded orphan drug designations to three investigational new active pharmaceutical ingredients (APIs). The three APIs are: 1) Alexion Pharmaceuticals’ ravulizumab...read more